Aeterna Zentaris to Announce First Quarter 2013 Financial and Operating Results on May 7, 2013 and Hold Annual Shareholders Meeting on May 8, 2013

About this update from Cosciens Biopharma Inc.

[{"type":"text","content":"\n\n\n\n\n\nQUEBEC CITY, May 1, 2013 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ:\n AEZS) (TSX: AEZ) (the \"Company\") will announce its first quarter 2013\n financial and operating results after market close on Tuesday, May 7,\n 2013. The Company will host a conference call to discuss these results\n on Wednesday, May 8, 2013, at 8:30 a.m., Eastern Time.\n\n\nParticipants may access the live webcast via the Company's website at www.aezsinc.com in the \"Newsroom\" section, or by telephone using the following numbers:\n in Canada, 514-807-9895 or 647-427-7450, outside Canada, 888-231-8191.\n A replay of the webcast will also be available on the Company's website\n for a period of 30 days.\n\n\nThe Company further announced that it will hold its Annual Shareholders\n Meeting also on Wednesday, May 8, 2013, starting at 10:30 a.m., Eastern\n Time, at the offices of Norton Rose Canada, 1 Place Ville Marie, Suite\n 2500, in Montreal, Canada.\n\n\nAbout Aeterna Zentaris \n\n\nAeterna Zentaris is an oncology and endocrinology drug development\n company currently investigating treatments for various unmet medical\n needs. The Company's pipeline encompasses compounds at all stages of\n development, from drug discovery through to marketed products. For more\n information please visit www.aezsinc.com.\n\nSOURCE: AETERNA ZENTARIS INC.\n\n\n Investor Relations Ginette Beaudet Vallières Investor Relations Coordinator (418) 652-8525 ext. [email protected] Media Relations Paul Burroughs Director of Communications (418) 652-8525 ext. [email protected] \n","length":2001,"tagName":"div"}]

More updates from Cosciens Biopharma Inc.